Skip to content
Triangle logo TriangleGet started
← Full study record

NCT00387764 · OUTCOME

Number of Participants With the Indicated Shift in Heart Rate From Baseline at Any Time Post-Baseline

Extension Study to VEG105192 to Assess Pazopanib in Patients With Advanced/Metastatic Renal Cell Cancer · Source last updated 2014-01-14

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
NUMBER
Unit
participants
Interval / dispersion
Not reported
Time frame
From Baseline to investigational product discontinuation (up to 6.230 years)

What was measured

Heart rate is the measure of heart beats per minute (bpm). The number of participants with a post-Baseline shift from Baseline in heart rate of \<44 bpm, 44 to 100 bpm, 101 to 120 bpm, and \>120 bpm was assessed.

Analysis population: ATS Population. Only those participants available at the specified time points were analyzed.

Groups in this outcome

Pazopanib 800 mg

Participants received pazopanib 800 milligrams (mg) once daily.

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
Pazopanib 800 mg79

Reported measurements

Heart rate <44 bpm
Values in participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Pazopanib 800 mg0Not reportedNot reportedNot reportedNot reported
Heart rate 44 to 100 bpm
Values in participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Pazopanib 800 mg66Not reportedNot reportedNot reportedNot reported
Heart rate 101 to 120 bpm
Values in participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Pazopanib 800 mg12Not reportedNot reportedNot reportedNot reported
Heart rate>120 bpm
Values in participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Pazopanib 800 mg1Not reportedNot reportedNot reportedNot reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        value
        0
    title
    Heart rate <44 bpm
  2. categories
    1. measurements
      1. group Id
        OG000
        value
        66
    title
    Heart rate 44 to 100 bpm
  3. categories
    1. measurements
      1. group Id
        OG000
        value
        12
    title
    Heart rate 101 to 120 bpm
  4. categories
    1. measurements
      1. group Id
        OG000
        value
        1
    title
    Heart rate>120 bpm
denoms
  1. counts
    1. group Id
      OG000
      value
      79
    units
    Participants
description
Heart rate is the measure of heart beats per minute (bpm). The number of participants with a post-Baseline shift from Baseline in heart rate of \<44 bpm, 44 to 100 bpm, 101 to 120 bpm, and \>120 bpm was assessed.
groups
  1. description
    Participants received pazopanib 800 milligrams (mg) once daily.
    id
    OG000
    title
    Pazopanib 800 mg
param Type
NUMBER
population Description
ATS Population. Only those participants available at the specified time points were analyzed.
reporting Status
POSTED
time Frame
From Baseline to investigational product discontinuation (up to 6.230 years)
title
Number of Participants With the Indicated Shift in Heart Rate From Baseline at Any Time Post-Baseline
type
PRIMARY
unit Of Measure
participants

Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0

Preserved source evidence · Not medical advice